← All trials
NCT06011343
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Oct 1, 2024
- Completion date
- Jul 1, 2025
- First posted
- Aug 25, 2023
- Last posted
- Aug 25, 2023
- Enrollment
- 22
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Federal University of BahiaLead sponsor
- Federal University of BahiaOverall official - principal investigator
- Federal University of BahiaReponsible party - principal investigator
- Federal University of BahiaSponsor investigator
- Instituto Gonçalo Muniz FIOCRUZ BACollaborator
- Federal University of BahiaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.